We're constantly growing our expertise in Immunology so that we can continue to discover and develop innovative medicines for patients living with debilitating diseases, such as systemic lupus erythematosus, rheumatoid arthritis, asthma, inflammatory bowel disease, and idiopathic pulmonary fibrosis.
At Genentech our research and discovery efforts into aspects of innate and adaptive immunity are applied to the understanding and treatment of autoimmune, inflammatory and fibrotic disorders. Studying how interactions between the immune system, stromal and epithelial cells, and the environment can become dysregulated in specialized tissues underlies our strategy to develop novel therapies for the treatment of autoimmune, inflammatory, and fibrotic diseases. We rely on human patient samples and biomarker data from observational and interventional clinical trials to define the pathogenic mechanisms and mechanistically distinct patient subsets underlying unmet medical needs in complex chronic diseases.
How a 20-year legacy of researching asthma has changed our understanding of the disease.